NEWS
We are excited to welcome NemaGen Discoveries to portfolio of companies in which we have invested. Founded by Mark C. Siracusa, PhD, Assistant Professor at Rutgers New Jersey Medical School, NemaGen is focused on advancing therapies to prevent allergic inflammation and mast-cell related diseases.
Congratulations to Kayothera, Inc. (a Foundation Venture Capital Group portfolio company), the BIO 2021 Start-up Stadium Winner!
